These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 35980344)

  • 1. Tau liquid-liquid phase separation: At the crossroads of tau physiology and tauopathy.
    Islam M; Shen F; Regmi D; Petersen K; Karim MRU; Du D
    J Cell Physiol; 2024 Jun; 239(6):e30853. PubMed ID: 35980344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau liquid-liquid phase separation in neurodegenerative diseases.
    Boyko S; Surewicz WK
    Trends Cell Biol; 2022 Jul; 32(7):611-623. PubMed ID: 35181198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid - liquid phase separation of tau: Driving forces, regulation, and biological implications.
    Li P; Chen J; Wang X; Su Z; Gao M; Huang Y
    Neurobiol Dis; 2023 Jul; 183():106167. PubMed ID: 37230179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase separation of the microtubule-associated protein tau.
    Chakraborty P; Zweckstetter M
    Essays Biochem; 2022 Dec; 66(7):1013-1021. PubMed ID: 36251053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure and phase of tau: from monomer to amyloid filament.
    Zeng Y; Yang J; Zhang B; Gao M; Su Z; Huang Y
    Cell Mol Life Sci; 2021 Mar; 78(5):1873-1886. PubMed ID: 33078207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-Associated Tau Phosphorylation Hinders Tubulin Assembly within Tau Condensates.
    Savastano A; Flores D; Kadavath H; Biernat J; Mandelkow E; Zweckstetter M
    Angew Chem Int Ed Engl; 2021 Jan; 60(2):726-730. PubMed ID: 33017094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation Disfavors Tau Phase Separation.
    Ferreon JC; Jain A; Choi KJ; Tsoi PS; MacKenzie KR; Jung SY; Ferreon AC
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic dipeptide-based small molecules modulate zinc-mediated liquid-liquid phase separation of tau.
    Ramesh M; Balachandra C; Baruah P; Govindaraju T
    J Pept Sci; 2023 May; 29(5):e3465. PubMed ID: 36471564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperoning shape-shifting tau in disease.
    Ryder BD; Wydorski PM; Hou Z; Joachimiak LA
    Trends Biochem Sci; 2022 Apr; 47(4):301-313. PubMed ID: 35045944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer's Disease and Other Tauopathies.
    Yang J; Shen N; Shen J; Yang Y; Li HL
    Mol Neurobiol; 2024 Jul; 61(7):4712-4731. PubMed ID: 38114762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc promotes liquid-liquid phase separation of tau protein.
    Singh V; Xu L; Boyko S; Surewicz K; Surewicz WK
    J Biol Chem; 2020 May; 295(18):5850-5856. PubMed ID: 32229582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathy: A common mechanism for neurodegeneration and brain aging.
    Saha P; Sen N
    Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
    Robert A; Schöll M; Vogels T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau liquid-liquid phase separation is modulated by the Ca
    Moreira GG; Gomes CM
    J Neurochem; 2023 Jul; 166(1):76-86. PubMed ID: 36621842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.
    Ballatore C; Brunden KR; Huryn DM; Trojanowski JQ; Lee VM; Smith AB
    J Med Chem; 2012 Nov; 55(21):8979-96. PubMed ID: 23020671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.